COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

A critical juncture

Leslie Galloway looks back over 2020, outlining the challenges faced by the life sciences sector and the potential opportunities that lie ahead
Responding to the crisis

Oli Hudson explores the changes that have occurred in the NHS this year as the Long Term Plan has been rolled out at speed in response to the COVID crisis
Movers and shakers

As mega deals slow, private capital becomes the driving force behind 2020 M&A

News

View all

PharmaTimes confirms INTCR 2021 virtual finals days

The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.

25th January 2021

Calquence tops Imbruvica in chronic lymphocytic leukaemia study

BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica

25th January 2021

NHS COVID-19 vaccination drive bolstered by new centres

Over 30 new vaccination centres open across England

25th January 2021

Psychiatry Consortium funds project investigating new schizophrenia treatments

Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim

25th January 2021

EU approval for Bavencio in bladder cancer

Approved for the maintenance treatment of advanced urothelial carcinoma

25th January 2021

Web Exclusives

View all

Opportunities for health tech in 2021

Where we might see growth drive innovation in the healthcare industry amid COVID-19 and beyond

A threat to innovation?

Could recent legal decisions on Supplementary Protection Certificates (SPCs) prove to be a hammer blow for the pharma industry?

Progress in personalised renal dosing

Dose adjustment based on a patient's renal function is a very current example of personalising therapy. While this kind of precision medicine holds great potential, it is often overlooked, particularly in younger patients. Darcie Streetman and Rachel Eyler explore the growing knowledge and tools available for optimising renal dosing.

Addressing inequalities in access to care

Improving standards of care nationwide with edge computing

Magazine

View more from the latest edition

SMART PEOPLE INSIGHT: Dr Jan Westerink

A new, pooled analysis of data from Novo Nordisk’s Phase III trials SUSTAIN 6 and PIONEER 6 shows that semaglutide may help patients with type 2 diabetes live longer without a cardiovascular event. PharmaTimes talks to lead study investigator Dr Jan Westerink about the importance of these findings

Targeting treatment

Will COVID help accelerate a more personalised approach to medicine?

Planning for the unpredictable

What 2020 has taught the pharma industry about the necessity of transforming regulatory information management

R&D trends

Accelerating innovation and its impact on patients and sites

Being a patient in 2020

Jenny Ousbey outlines the patient experience and developments in advocacy

Movers and shakers

As mega deals slow, private capital becomes the driving force behind 2020 M&A

Responding to the crisis

Oli Hudson explores the changes that have occurred in the NHS this year as the Long Term Plan has been rolled out at speed in response to the COVID crisis